Immune responses induced by primary vaccination with the PHiD-CV Commercial lot were non-inferior to the Phase III Clinical lot in terms of adjusted antibody geometric mean concentration ( GMC ) ratios for each vaccine pneumococcal serotype and protein D. For each vaccine pneumococcal serotype , @ % and @ % of infants from Malaysia and Singapore had post-primary vaccination antibody concentrations @ g/mL and OPA titres @ , in the Clin and Com groups , respectively .